Diagnostic tests should be assessed for clinical impact
Authors:
- Jonathan D. BaghdadiJBJonathan D. Baghdadi
- Daniel J. MorganDMDaniel J. Morgan
Open Access
- 25 July 2024
- journal article
- Published by Elsevier in CMI Communications
- Vol. 1 (2)
Abstract
No abstract availableFunding Information
- Agency for Healthcare Research and Quality (K08HS028854)
This publication has 15 references indexed in Scilit:
- Reporting of Observational Studies Explicitly Aiming to Emulate Randomized TrialsJAMA Network Open, 2023
- Developing a diagnosis calculator to estimate the probability of bacterial pneumoniaAntimicrobial Stewardship & Healthcare Epidemiology, 2023
- Exploration of Primary Care Clinician Attitudes and Cognitive Characteristics Associated With Prescribing Antibiotics for Asymptomatic BacteriuriaJAMA Network Open, 2022
- Accuracy of Practitioner Estimates of Probability of Diagnosis Before and After TestingJAMA Internal Medicine, 2021
- Days alive and free as an alternative to a mortality outcome in pivotal vasopressor and septic shock trialsJournal of Critical Care, 2018
- Procalcitonin-Guided Use of Antibiotics for Lower Respiratory Tract InfectionNew England Journal of Medicine, 2018
- Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trialThe Lancet Respiratory Medicine, 2017
- Overdiagnosis ofClostridium difficileInfection in the Molecular Test EraJAMA Internal Medicine, 2015
- Desirability of Outcome Ranking (DOOR) and Response Adjusted for Duration of Antibiotic Risk (RADAR)Clinical Infectious Diseases, 2015
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesThe Lancet, 2007